Application Sponsors
ANDA 202235 | SAGENT PHARMS INC | |
Marketing Status
Application Products
001 | INJECTABLE;INTRAVENOUS | EQ 3MG BASE/3ML | 0 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
FDA Submissions
| ORIG | 1 | AP | 2014-09-02 | |
LABELING; Labeling | SUPPL | 3 | AP | 2019-12-13 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2019-12-13 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 19 |
SUPPL | 3 | Null | 15 |
SUPPL | 4 | Null | 15 |
TE Codes
CDER Filings
SAGENT PHARMS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 202235
[companyName] => SAGENT PHARMS INC
[docInserts] => ["",""]
[products] => [{"drugName":"IBANDRONATE SODIUM","activeIngredients":"IBANDRONATE SODIUM","strength":"EQ 3MG BASE\/3ML","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"09\/02\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"12\/13\/2019","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"12\/13\/2019","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"12\/13\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Medication Guide, Labeling-Container\/Carton Labels, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2019-12-13
)
)